The global IVD reagents market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth in this market is attributed to the increasing demand for IVD reagents in various applications such as immuno diagnostics, chemistry diagnostics, molecular diagnostics and POCT. The increasing number of patients suffering from chronic diseases such as diabetes and cancer are also driving the growth of this market. Immuno Diagnostics: The immuno diagnostic segment accounted for the largest share in 2018 and is expected to continue its dominance throughout the forecast period due to its wide range of applications across various industries including healthcare, food & beverage, agriculture and others. This segment is expected to grow at a CAGR of 6% during the forecast period owing to factors such as increased demand for point-of-care testing (POCT) devices which use chemistry diagnostic reagents among other factors.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of chronic diseases such as diabetes and cancer is driving the growth of the IVD Reagents market.
- The increasing demand for point-of-care testing in emerging economies such as China, India, and Brazil is also driving the growth of the IVD Reagents market.
- Increasing government initiatives for healthcare reforms in developed countries such as Japan and Germany are also driving the growth of the IVD Reagents market.
- Increasing investments by pharmaceutical companies in research & development activities are also driving the growth of this market.
Industry Growth Insights published a new data on “IVD Reagents Market”. The research report is titled “IVD Reagents Market research by Types (Immuno Diagnostics, Chemistry Diagnostics, Molecular Diagnostics, POCT, Other), By Applications (Hospitals, Laboratory, Other), By Players/Companies Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, Biomerieux, Ortho Clinical Diagnostics, Becton Dickinson, Bio-Rad Laboratories, Hologic, Johnson and Johnson, Qiagen, Myriad Genetics, Wondfo, KHB, DAAN Gene, Leadman Biochemistry, Mindray, BioSino”.
Scope Of The Report
Report Attributes
Report Details
Report Title
IVD Reagents Market Research Report
By Type
Immuno Diagnostics, Chemistry Diagnostics, Molecular Diagnostics, POCT, Other
By Application
Hospitals, Laboratory, Other
By Companies
Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, Biomerieux, Ortho Clinical Diagnostics, Becton Dickinson, Bio-Rad Laboratories, Hologic, Johnson and Johnson, Qiagen, Myriad Genetics, Wondfo, KHB, DAAN Gene, Leadman Biochemistry, Mindray, BioSino
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global IVD Reagents Market Report Segments:
The global IVD Reagents market is segmented on the basis of:
Types
Immuno Diagnostics, Chemistry Diagnostics, Molecular Diagnostics, POCT, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Laboratory, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Abbott
- Danaher
- Siemens Healthineers
- Thermo Fisher Scientific
- Sysmex
- Biomerieux
- Ortho Clinical Diagnostics
- Becton Dickinson
- Bio-Rad Laboratories
- Hologic
- Johnson and Johnson
- Qiagen
- Myriad Genetics
- Wondfo
- KHB
- DAAN Gene
- Leadman Biochemistry
- Mindray
- BioSino
Highlights of The IVD Reagents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immuno Diagnostics
- Chemistry Diagnostics
- Molecular Diagnostics
- POCT
- Other
- By Application:
- Hospitals
- Laboratory
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the IVD Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
IVD reagents are a type of laboratory chemicals that are used in medical testing. IVD reagents can be used to test for the presence of specific substances in blood, urine, or other body fluids.
Some of the major companies in the ivd reagents market are Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, Biomerieux, Ortho Clinical Diagnostics, Becton Dickinson, Bio-Rad Laboratories, Hologic, Johnson and Johnson, Qiagen, Myriad Genetics, Wondfo, KHB, DAAN Gene, Leadman Biochemistry, Mindray, BioSino.
The ivd reagents market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. IVD Reagents Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. IVD Reagents Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. IVD Reagents Market - Supply Chain
4.5. Global IVD Reagents Market Forecast
4.5.1. IVD Reagents Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. IVD Reagents Market Size (000 Units) and Y-o-Y Growth
4.5.3. IVD Reagents Market Absolute $ Opportunity
5. Global IVD Reagents Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. IVD Reagents Market Size and Volume Forecast by Type
5.3.1. Immuno Diagnostics
5.3.2. Chemistry Diagnostics
5.3.3. Molecular Diagnostics
5.3.4. POCT
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global IVD Reagents Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. IVD Reagents Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Laboratory
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global IVD Reagents Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. IVD Reagents Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global IVD Reagents Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. IVD Reagents Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global IVD Reagents Demand Share Forecast, 2019-2026
9. North America IVD Reagents Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America IVD Reagents Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America IVD Reagents Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Laboratory
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America IVD Reagents Market Size and Volume Forecast by Type
9.7.1. Immuno Diagnostics
9.7.2. Chemistry Diagnostics
9.7.3. Molecular Diagnostics
9.7.4. POCT
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America IVD Reagents Demand Share Forecast, 2019-2026
10. Latin America IVD Reagents Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America IVD Reagents Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America IVD Reagents Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Laboratory
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America IVD Reagents Market Size and Volume Forecast by Type
10.7.1. Immuno Diagnostics
10.7.2. Chemistry Diagnostics
10.7.3. Molecular Diagnostics
10.7.4. POCT
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America IVD Reagents Demand Share Forecast, 2019-2026
11. Europe IVD Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe IVD Reagents Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe IVD Reagents Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Laboratory
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe IVD Reagents Market Size and Volume Forecast by Type
11.7.1. Immuno Diagnostics
11.7.2. Chemistry Diagnostics
11.7.3. Molecular Diagnostics
11.7.4. POCT
11.7.5. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Maket Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe IVD Reagents Demand Share, 2019-2026
12. Asia Pacific IVD Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific IVD Reagents Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific IVD Reagents Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Laboratory
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific IVD Reagents Market Size and Volume Forecast by Type
12.7.1. Immuno Diagnostics
12.7.2. Chemistry Diagnostics
12.7.3. Molecular Diagnostics
12.7.4. POCT
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific IVD Reagents Demand Share, 2019-2026
13. Middle East & Africa IVD Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa IVD Reagents Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa IVD Reagents Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Laboratory
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa IVD Reagents Market Size and Volume Forecast by Type
13.7.1. Immuno Diagnostics
13.7.2. Chemistry Diagnostics
13.7.3. Molecular Diagnostics
13.7.4. POCT
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa IVD Reagents Demand Share, 2019-2026
14. Competition Landscape
14.1. Global IVD Reagents Market: Market Share Analysis
14.2. IVD Reagents Distributors and Customers
14.3. IVD Reagents Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Siemens Healthineers
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Thermo Fisher Scientific
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sysmex
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Biomerieux
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Ortho Clinical Diagnostics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Becton Dickinson
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bio-Rad Laboratories
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Hologic
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Johnson and Johnson
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Qiagen
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Myriad Genetics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Wondfo
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. KHB
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. DAAN Gene
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Leadman Biochemistry
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Mindray
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. BioSino
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook